Press

GenPrime and Rhea, two leading players in reproductive health, have teamed up to revolutionize fertility care globally. With a fresh injection of $10 million in funding, led by Thiel Capital and supported by LifeX Ventures, Blue Lion Global, and FJ Labs, the collaboration will accelerate the development of a seamless, end-to-end fertility ecosystem.

Rhea, a global leader in reproductive health services, is proud to introduce GenPrime, its cutting-edge fertility service platform, as part of a comprehensive end-to-end reproductive health ecosystem. GenPrime is designed to streamline the fertility journey for modern families, offering a global network of owned and partner clinics, all integrated with Rhea’s advanced technology platform, Rhea Labs.

Rhea’s services ecosystem is centered around a global network of owned and partner clinics. This ecosystem is powered by Rhea Labs, an integrated technology platform that leverages data, accelerated time to market, and quality product feedback loops to improve patient outcomes. The company’s fertility services are delivered by Rhea’s patient journey management tools and clinic network, Generation Prime, which has formally rebranded as GenPrime.

In a strategic move to transform women’s healthcare, Recharge Capital has appointed a senior executive from Bridgewater Associates to lead its initiatives, placing a strong emphasis on GenPrime’s role as a key driver in reproductive health innovation. With a global network of clinics and cutting-edge technology, GenPrime is poised to redefine fertility care through a seamless, integrated approach.